Noemi Käslin takes over the Life Sciences divison for Flexsis and albedis as Business Director Life Sciences  

• Life Sciences

With her promotion to Business Director Life Sciences, Noemi Käslin is taking on a key role at albedis and Flexsis. Not only has she built the life sciences division from the ground up since she joined the company in 2020, she has also made it one of Flexsis’ strongest growth segments. Her journey has been characterised by hard work, expertise and a clear vision: connecting specialised talent with companies that are shaping the future of the industry.   

Born and raised in Basel, she started her career in work integration, where she supported people in their professional integration. Later, she switched to recruitment and took on management positions in areas such as commercial professions, IT and Life Sciences. When she started at Flexsis, she initially had a small share of blue-collar profiles in the life sciences sector and built this and her white-collar share while running a “one-woman-show”. Thanks to her commitment, she was able to build a highly qualified team and at the same time achieve a sustainable positioning in a highly regulated market.   

Turning challenges into success  

One of her biggest achievements was winning the tender from a leading Swiss company. This success laid the foundation for the expansion of the life sciences division. “When I first started working, the market was heavily focused on blue-collar positions. The shift towards specialised white-collar solutions was challenging, but also very rewarding,” Käslin recalls. Her approach: high quality solutions tailored to the individual needs of clients. This focus has not only enabled her to build long-term partnerships, but also to raise the quality and reliability of the Life Sciences division to a new level.  

A clear vision for the future  

Noemi Käslin sees her new position as recognition of her previous work and also as an obligation to further develop the division. “My goal is to further expand the life sciences division and to strengthen it sustainably through innovative recruitment solutions,” she explains. With the strategic decision to specialise Flexsis’ Zurich office in life sciences, she has taken an important step towards securing the future.  

“Our specialisation is our greatest asset. It enables us not only to meet the highest standards, but also to create real added value for our clients,” says Noemi Käslin. This specialisation will be further strengthened on a national and international level.  

A future-oriented industry with potential  

Noemi Käslin is inspired by the dynamic and international character of the life sciences industry. “Every project we support contributes to the thriving innovative developments of the industry – from research and development to production. It is incredibly fulfilling to be part of theses success stories.”  

In her new role, Käslin aims to further strengthen the positioning of both brands – albedis and Flexsis – and establish them as reliable partners for contraction, permanent recruitment and mandate solutions in Life Sciences. Her recipe for success remains unchanged: quality, specialisation and an unwavering passion for successfully connecting people with and companies together.